Moxifloxacin and Clonazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moxifloxacin and Clonazepam. Common interactions include wheezing among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Moxifloxacin and Clonazepam have. It is created by eHealthMe based on reports of 98 people who take Moxifloxacin and Clonazepam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 02, 2023

98 people who take Moxifloxacin and Clonazepam together, and have interactions are studied.

What is Moxifloxacin?

Moxifloxacin has active ingredients of moxifloxacin. eHealthMe is studying from 9,510 Moxifloxacin users for its effectiveness, alternative drugs and more.

What is Clonazepam?

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. eHealthMe is studying from 128,334 Clonazepam users for its effectiveness, alternative drugs and more.

Number of Moxifloxacin and Clonazepam reports submitted per year:

Common Moxifloxacin and Clonazepam drug interactions by gender *:

female:

Wheezing
Drug hypersensitivity
Vomiting
Rhinorrhoea
Tremor
Chronic obstructive pulmonary disease
Pain
Respiratory tract infection
Chest pain
Nasal oedema

male:

Chronic kidney disease
Renal failure
Arthralgia
Blood creatinine increased
Cardiac failure
Dacryolith
Death
Fatigue
Insomnia
Rash

Common Moxifloxacin and Clonazepam drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Blood cholesterol increased
Blood glucose increased
Hypertriglyceridaemia

30-39:

Anhedonia
Chronic kidney disease
Complications of transplanted kidney
Depression
Emotional distress
Immunodeficiency
Mobility decreased
Osteopenia
Overdose
Pain

40-49:

Chronic kidney disease
Anhedonia
Emotional distress
Pain
Renal failure
Arthralgia
Asthenia
Balance disorder
Blood creatinine increased
Depression

50-59:

Hypoxia
Idiopathic pulmonary fibrosis
Incontinence
Injection site bruising
Injection site reaction
Lip swelling
Liver disorder
Nausea
Pneumonia
Rash papular

60+:

Pneumonia
Dyspnoea
Rhinorrhoea
Chronic obstructive pulmonary disease
Vomiting
Pulmonary embolism
Respiratory disorder
Respiratory tract infection
Sinusitis
Chest pain

Common conditions people have *:

Pain: 19 people, 19.39%
Pneumonia: 18 people, 18.37%
Asthma: 15 people, 15.31%
Non-Small Cell Lung Cancer Stage 0: 15 people, 15.31%
Infection: 12 people, 12.24%
Headache (pain in head): 11 people, 11.22%
High Blood Cholesterol: 10 people, 10.20%
High Blood Pressure: 9 people, 9.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 8.16%
Wheezing (a high-pitched whistling sound made while you breath): 8 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Moxifloxacin and Clonazepam?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

McFarlane SI, "Torsades de Pointes induced by Methadone and Clonazepam Use", , 2015 Jan .
Ashkar AG, Goldberg T, Maraj I, Masters A, McFarlane SI, "Torsades De Pointes Induced by Methadone and Clonazepam Use", International Journal of Medical and Pharmaceutical Case Reports, 2015 Jan .
McFarlane, S. I. , "Torsades de Pointes induced by Methadone and Clonazepam Use", , 2014 Jan .